Svenska
Boston
An independent LDT provider
Home
About us
Home
About us
Learn more
Vision and mission
Leadership
About us
Leadership
Learn more
Board of directors
Management team
Medical Advisory Board
Collaborations
About us
Collaborations
Learn more
Patient Advocacy Support
Immunovia, Inc.
Immunovia Dx Laboratory, Lund
Company history
Sustainability
About us
Sustainability
Learn more
Sustainability report
Code of conduct
Work environment
Diversity
Calendar
Careers
IMMray™ Platform
Home
IMMray™ Platform
Learn more
Technology
Production
Pancreatic Cancer
IMMray™ Platform
Pancreatic Cancer
Learn more
Pancreatic cancer high risk groups
Clinical performance
Clinical prospective study program
Current technologies for detection and diagnosis
Pipeline
IMMray™ Platform
Pipeline
Learn more
Lung cancer
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Webinars
Tutorials
Videos
Audio
Publications
Social media
Media resources
Partnering
Contact Us
Subscribe
Immunovia Inc
English
Svenska
Press releases
Type
All types
Regulatory
Non regulatory
Year
All years
2022
2021
2020
2019
2018
2017
2016
2015
May 23, 2022
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states
Read press release
May 17, 2022
Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states
Read press release
May 16, 2022
Immunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access US
Read press release
April 28, 2022
| REGULATORY
Immunovia Publishes Interim Report January-March 2022
Read press release
April 21, 2022
Invitation to Immunovia’s Q1 presentation
Read press release
April 14, 2022
| REGULATORY
Immunovia CPT PLA Code submission for the IMMray™ PanCan-d test is on the agenda of American Medical Association
Read press release
April 7, 2022
| REGULATORY
Communiqué from the Annual General Meeting in Immunovia AB
Read press release
March 28, 2022
| REGULATORY
Immunovia appoints Jeff Borcherding, previously Chief Marketing Officer at Myriad Genetics, to lead Immunovia’s US business
Read press release
March 10, 2022
| REGULATORY
Immunovia publishes the annual report for 2021
Read press release
March 8, 2022
Immunovia, Inc. Laboratory Receives Accreditation from College of American Pathologists – a major step in the nationwide US roll-out of IMMray™ PanCan-d
Read press release
March 7, 2022
Immunovia further strengthens IP portfolio for its IMMray™ PanCan-d signature
Read press release
March 4, 2022
| REGULATORY
Notice to the Annual General Meeting of Immunovia AB (publ)
Read press release
1
2
3
…
22
>
Home
Press releases